Antioxidative 0-dimensional nanodrugs overcome obstacles in AKI antioxidant therapy

Y Yang, Y Nan, Q Chen, Z Xiao, Y Zhang… - Journal of Materials …, 2023 - pubs.rsc.org
Acute kidney injury (AKI) is a commonly encountered syndrome associated with various
aetiologies and pathophysiological processes leading to enormous health risks and …

Machine learning for acute kidney injury: Changing the traditional disease prediction mode

X Yu, Y Ji, M Huang, Z Feng - Frontiers in Medicine, 2023 - frontiersin.org
Acute kidney injury (AKI) is a serious clinical comorbidity with clear short-term and long-term
prognostic implications for inpatients. The diversity of risk factors for AKI has been …

Cardiovascular, pulmonary, and neuropsychiatric short-and long-term complications of COVID-19

M Kobusiak-Prokopowicz, K Fułek, M Fułek, K Kaaz… - Cells, 2022 - mdpi.com
Beginning with the various strategies of the SARS-CoV-2 virus to invade our bodies and
manifest infection, and ending with the recent long COVID, we are witnessing the evolving …

Zilebesiran—the first siRNA-based drug in hypertensiology: why is it needed, and will it change the treatment approach of hypertension?

S Surma, S Oparil - Arterial Hypertension, 2024 - journals.viamedica.pl
Arterial hypertension is the most common cardiovascular risk factor in the world. The
prevalence of hypertension has doubled over the last 30 years. Despite the availability of …

COVID-19 and Clostridioides difficile Coinfection Outcomes among Hospitalized Patients in the United States: An Insight from National Inpatient Database

RU Awan, K Gangu, A Nguyen, P Chourasia… - Infectious Disease …, 2023 - mdpi.com
The incidence of Clostridioides difficile infection (CDI) has been increasing compared to pre-
COVID-19 pandemic levels. The COVID-19 infection and CDI relationship can be affected by …

Risk factors for acute kidney injury in patients hospitalized with COVID-19

CL Arenas, ACP Forero, DCV Ángel… - Brazilian Journal of …, 2023 - SciELO Brasil
Introduction: Acute kidney injury (AKI) occurs frequently in COVID-19 patients and is
associated with greater morbidity and mortality. Knowing the risks of AKI allows for …

Emodin inhibits M1 macrophage activation that related to acute and chronic kidney injury through EGFR/MAPK pathway

W Xiong, J Tang, H Yu, Y Luo, M Yu, Y Li - Functional & Integrative …, 2024 - Springer
Background Macrophages are the main inflammatory cells involved in kidney injury and play
a significant role in the development of acute kidney injury (AKI) and progression of chronic …

Development and validation of a Multi-Causal investigation and discovery framework for knowledge harmonization (MINDMerge): A case study with acute kidney …

M Zhang, X Zhang, M Dai, L Wu, K Liu, H Wang… - International Journal of …, 2024 - Elsevier
Objective Accurate diagnoses and personalized treatments in medicine rely on identifying
causality. However, existing causal discovery algorithms often yield inconsistent results due …

Long journey on the role of long non-coding RNA (lncRNA) in acute kidney injury (AKI)

HO Alsaab, AF Al Agile, RN Alsaeedi… - … -Research and Practice, 2024 - Elsevier
Acute kidney injury (AKI) has a high rate of morbidity, death, and medical expenses, making
it a worldwide public health problem. There are still few viable treatment plans for AKI …

Predictors of Acute Kidney Injury (AKI) among COVID-19 Patients at the US Department of Veterans Affairs: The Important Role of COVID-19 Vaccinations

LR Lukowsky, C Der-Martirosian, H Northcraft… - Vaccines, 2024 - mdpi.com
Background: There are knowledge gaps about factors associated with acute kidney injury
(AKI) among COVID-19 patients. To examine AKI predictors among COVID-19 patients, a …